EUVIMEDEUVIMED entdecken
Crossref

Emergence of xylazine as a public health threat: what does the anesthesiologist need to know for perioperative care?

Pawan K Solanki iD, Samir Yellapragada, Brendan Lynch, Maria Eibel, Eugene R Viscusi iD, Trent Emerick iD

Regional Anesthesia & Pain Medicine · 2025

DOI: 10.1136/rapm-2023-105190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Regional Anesthesia & Pain Medicine, 2025. Verfasst von Pawan K Solanki und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Chronic Pain Division, UPMC, Pittsburgh, Pennsylvania, USA solankipk3@upmc.edu. Hauptthemen laut MEDLINE: Anesthesiologists, Perioperative Care, Public Health, Xylazine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This paper explores the rapid emergence of xylazine exposure in the USA and its implications for anesthesiologists. Xylazine, a non-opioid sedative and analgesic often used in veterinary medicine, has increasingly been found as an adulterant in the illicit substance supply, leading to serious health implications. The pharmacological properties of xylazine, its clinical effects, and the challenges it poses for clinicans will be discussed. Perioperative strategies for anesthesiologists to manage these potential cases are provided. Furthermore, this paper necessitates an epidemiological understanding for detection and multidisciplinary collaboration in addressing this emerging public health threat. The manuscript concludes by emphasizing the role anesthesiologists will have to play in managing the clinical implications of xylazine and contributing to public health strategies aimed at curbing its misuse.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnesthesiologistsPerioperative CarePublic HealthXylazineVeterinary DrugsHumansHypnotics and Sedatives

Stichwörter der Autor:innen

anesthesia, conductiondrug-related side effects and adverse reactionseducationoutcome assessment, health carepatient education as topic

Substanzen

Hypnotics and SedativesXylazineVeterinary Drugs

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, Chronic Pain Division, UPMC, Pittsburgh, Pennsylvania, USA solankipk3@upmc.edu.
  • Department of Anesthesiology and Perioperative Medicine, Chronic Pain Division, UPMC, Pittsburgh, Pennsylvania, USA.
  • Anesthesiology and Perioperative Medicine, Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Pawan K Solanki, Eugene R Viscusi, Trent Emerick

Zitieren

APA

Solanki, P. K., Yellapragada, S., Lynch, B., Eibel, M., Viscusi, E. R., & Emerick, T. (2025). Emergence of xylazine as a public health threat: what does the anesthesiologist need to know for perioperative care?. Regional Anesthesia & Pain Medicine. https://doi.org/10.1136/rapm-2023-105190

Vancouver

Solanki PK, Yellapragada S, Lynch B, Eibel M, Viscusi ER, Emerick T. Emergence of xylazine as a public health threat: what does the anesthesiologist need to know for perioperative care?. Regional Anesthesia & Pain Medicine. 2025. doi:10.1136/rapm-2023-105190

BibTeX
@article{Solanki2025,
  author = {Solanki, Pawan K and Yellapragada, Samir and Lynch, Brendan and Eibel, Maria and Viscusi, Eugene R and Emerick, Trent},
  title = {Emergence of xylazine as a public health threat: what does the anesthesiologist need to know for perioperative care?},
  journal = {Regional Anesthesia & Pain Medicine},
  year = {2025},
  doi = {10.1136/rapm-2023-105190}
}
Kostenlos starten →